|
Defining the Clinical Pathway for the Emerging Valve Space
Structural heart disease, a pervasive disease worldwide, which includes mitral valve regurgitation as one of its symptoms, used to have a variety of surgical approaches, using tissue-based or mechanical valves. However, these procedures were highly invasive...
|
|
PCSK9 inhibition could ameliorate cardiovascular disease by immune mechanisms
PCSK9 inhibition could ameliorate atherosclerosis and thus cardiovascular disease by immune mechanisms that are unrelated to lowering of low-density lipoprotein (LDL) cholesterol, according to research presented...
|
|